High-density lipoprotein cholesterol efflux capacity in patients with obstructive sleep apnea and its relation with disease severity

Abstract Background Obstructive sleep apnea (OSA) is linked to an accelerated risk of cardiovascular disease (CVD). Some key CVD risk factors are present in patients suffering from OSA such as hypertension, inflammation, oxidative stress, and dyslipidemia. High-density lipoprotein (HDL) cholesterol...

Full description

Bibliographic Details
Published in:	Lipids in Health and Disease
Main Authors:	Reza Fadaei, Samaneh Mohassel Azadi, Eric Rhéaume, Habibolah Khazaie
Format:	Article
Language:	English
Published:	BMC 2022-11-01
Subjects:	HDL function Anti-oxidant Apolipoprotein Dyslipidemia Cholesterol efflux Apnea
Online Access:	https://doi.org/10.1186/s12944-022-01723-w

Similar Items

Lower than average HDL cholesterol efflux capacity in Lithuanian population
by: Sandra Kutkiene, et al.
Published: (2019-10-01)

Management of triglycerides, non-high density lipoprotein cholesterol and high density lipoprotein cholesterol
by: Geevar Zachariah
Published: (2024-03-01)

Cuban policosanol improves high-density lipoprotein cholesterol efflux capacity in healthy Japanese subjects
by: Yoshinari Uehara, et al.
Published: (2024-01-01)

Effects of flavonoids on cholesterol efflux capability
by: Maha Abdulmajeed Ayoub
Published: (2022-09-01)

Impact of metabolic-associated fatty liver disease on the cholesterol efflux capacity of high-density lipoproteins in adolescents with type 2 diabetes
by: José Antonio Orozco Morales, et al.
Published: (2024-12-01)

Moderate‐ and High‐Intensity Exercise Improves Lipoprotein Profile and Cholesterol Efflux Capacity in Healthy Young Men
by: Kelly M. Stanton, et al.
Published: (2022-06-01)

Capacity of HDL to Efflux Cellular Cholesterol from Lipid-Loaded Macrophages Is Reduced in Patients with Familial Hypercholesterolemia
by: Shiva Ganjali, et al.
Published: (2023-01-01)

Cellular cholesterol efflux in heterozygotes for Tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size
by: Margaret E. Brousseau, et al.
Published: (2000-07-01)

α-Synuclein Regulates Neuronal Cholesterol Efflux
by: Jen-Hsiang T. Hsiao, et al.
Published: (2017-10-01)

HDL, cholesterol efflux, and ABCA1: Free from good and evil dualism
by: Masatsune Ogura
Published: (2022-10-01)

Lack of Correlation of Plasma HDL With Fecal Cholesterol and Plasma Cholesterol Efflux Capacity Suggests Importance of HDL Functionality in Attenuation of Atherosclerosis
by: Neelam Srivastava, et al.
Published: (2018-09-01)

The Human ABCG1 Transporter Mobilizes Plasma Membrane and Late Endosomal Non-Sphingomyelin-Associated-Cholesterol for Efflux and Esterification
by: Edward B. Neufeld, et al.
Published: (2014-12-01)

Gestational Hypertension and High-Density Lipoprotein Function: An Explorative Study in Overweight/Obese Women of the DALI Cohort
by: Julia T. Stadler, et al.
Published: (2022-12-01)

Monocyte/high-density lipoprotein cholesterol, neutrophil/high-density lipoprotein cholesterol, and lymphocyte/high-density lipoprotein cholesterol ratios as new inflammatory markers in rosacea
by: Bülent Nuri Kalaycı
Published: (2023-06-01)

Antiatherosclerotic Effects of CSL112 Mediated by Enhanced Cholesterol Efflux Capacity
by: Bronwyn A. Kingwell, et al.
Published: (2022-04-01)

Cholesterol Efflux Efficiency of Reconstituted HDL Is Affected by Nanoparticle Lipid Composition
by: Shifa Jebari-Benslaiman, et al.
Published: (2020-09-01)

Testing the role of apoA-I, HDL, and cholesterol efflux in the atheroprotective action of low-level apoE expression
by: Fayanne E. Thorngate, et al.
Published: (2003-12-01)

Remnant cholesterol associates with hypertension beyond low-density lipoprotein cholesterol among the general US adult population
by: Liu Shi, et al.
Published: (2023-09-01)

HDL Functionality in Metabolic Syndrome: Insights From Cholesterol Efflux Capacity and NMR Spectroscopy
by: A. Anita Sherly, et al.
Published: (2025-08-01)

Cholesterol Efflux Capacity and Cardiovascular Disease: The Ludwigshafen Risk and Cardiovascular Health (LURIC) Study
by: Andreas Ritsch, et al.
Published: (2020-11-01)

Probucol treatment is associated with an ABCA1-independent mechanism of cholesterol efflux to lipid poor apolipoproteins from foam cell macrophages
by: Anouar Hafiane, MSc, PhD, et al.
Published: (2021-01-01)

Low HDL Cholesterol Efflux Capacity Indicates a Fatal Course of COVID-19
by: Julia T. Stadler, et al.
Published: (2022-09-01)

Macrophage Cholesterol Efflux Downregulation Is Not Associated with Abdominal Aortic Aneurysm (AAA) Progression
by: Marina Canyelles, et al.
Published: (2020-04-01)

Triglyceride to high-density lipoprotein cholesterol and low-density lipoprotein cholestrol to high-density lipoprotein cholesterol ratios are predictors of cardiovascular risk in Iranian adults: Evidence from a population-based cross-sectional study
by: Karimollah Hajian-Tilaki, et al.
Published: (2020-01-01)

ATP hydrolysis-dependent conformational changes in the extracellular domain of ABCA1 are associated with apoA-I binding[S]
by: Kohjiro Nagao, et al.
Published: (2012-01-01)

Improvements in cholesterol efflux capacity of HDL after bariatric surgery in patients with obesity: a meta-analysis
by: Tannaz Jamialahmadi, et al.
Published: (2025-10-01)

Cholesterol efflux capacity of high‐density lipoprotein was not associated with cognitive decline and brain structures in older people with diabetes mellitus
by: Yuanyuan Wu, et al.
Published: (2022-11-01)

Analysis of some biomarkers of dyslipidemia in obstructive sleep apnea and obese patients
by: A. V. Yakovlev, et al.
Published: (2014-12-01)

High-density lipoprotein functionality in cholesterol efflux in early childhood is related to the content ratio of triglyceride to cholesterol
by: Akiko Futatsugi, et al.
Published: (2024-10-01)

Clinical remission in newly diagnosed type 1 diabetes mellitus and HDL function on cholesterol efflux capacity: prospective InLipoDiab1 study
by: Aleksandra Uruska, et al.
Published: (2025-06-01)

Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Phosphate Accelerates Cellular Cholesterol Efflux in THP-1 Cells
by: Tomohiro Komatsu, et al.
Published: (2023-01-01)

High-Density Lipoprotein Changes in Alzheimer’s Disease Are <i>APOE</i> Genotype-Specific
by: Brian V. Hong, et al.
Published: (2022-06-01)

Human apoA-I[Lys107del] mutation affects lipid surface behavior of apoA-I and its ability to form large nascent HDL
by: Irina N. Gorshkova, et al.
Published: (2023-02-01)

Correlation between TG/HDL-C ratio and obstructive sleep apnea in the adult US population: a cross-sectional study
by: Yanlin Yang, et al.
Published: (2025-06-01)

Reconfiguring Nature’s Cholesterol Accepting Lipoproteins as Nanoparticle Platforms for Transport and Delivery of Therapeutic and Imaging Agents
by: Skylar T. Chuang, et al.
Published: (2020-05-01)

Bariatric Surgery Improves HDL Function Examined by ApoA1 Exchange Rate and Cholesterol Efflux Capacity in Patients with Obesity and Type 2 Diabetes
by: Shuhui Wang Lorkowski, et al.
Published: (2020-04-01)

High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives
by: Maria Pia Adorni, et al.
Published: (2021-03-01)

The Role of the Lymphatic System in Cholesterol Transport
by: Li-Hao eHuang, et al.
Published: (2015-09-01)

Lomitapide modifies high-density lipoprotein function in homozygous familial hypercholesterolaemia
by: Anouar Hafiane, et al.
Published: (2025-04-01)

High Density Lipoprotein-Based Therapeutics: Novel Mechanism of Probucol in Foam Cells
by: Anouar Hafiane, et al.
Published: (2022-04-01)